Brief: Samsung Pharmaceutical signs contract worth 51.09 bln won

Samsung Pharm

09/12/2016 07:43

Dec 9 (Reuters) - Samsung Pharmaceutical Co Ltd  001360.KS  
: 
 
    * Says it signs contract with Newtheranex to provide sole 
marketing rights of Gasmyungsoo series medicine in domestic 
market 
    * Contract amount is 51.09 billion won  
 
     
     
    Source text in Korean: https://goo.gl/0zsz3E 
    Further company coverage:  001360.KS  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))